-
Published in:
Transfuze Hematol. dnes,27, 2021, No. Supplementum 1, p. 1-212.
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today

- Neutralizing Antibodies Against Emicizumab – Detailed Analysis Based on a Case Study
- Position of aPCC in the Treatment of Hemophilia A Complicated by the Development of Inhibitors
- Sport and Physical Activity Benefit Hemophiliacs
- What FVIII Levels Are Ideal for Preventing Bleeding in Hemophilia A?
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
Most read in this issue